Peter Shippen, CFA
Peter is the CEO of Britannia Life Sciences. He previously founded and grew Redwood Asset Management until it was ultimately sold to Purpose Investments. As an early investor in the Canadian cannabis market, Peter was involved in the conception of the Medical Cannabis and Wellness ETF that is listed on the LSE under CBDX. He has served on multiple boards of directors for both private and public companies.